Browse Studies — Arctuva

Observational

ENhancing Exercise With LIGHT to Improve Functioning in PAD: the ENLIGHTEN PAD Trial

The ENLIGHTEN PAD Trial will collect preliminary data to test whether daily 660 nm light treatment of the lower extremities immediately before home-based walki…

Peripheral Artery DiseasePeripheral Vascular DiseaseAging+1 more

Estimated

~$10 – $6,250

Northwestern UniversityNCT06399900

POst-Market ClINical Follow-up STudy oF the SerranatOR PTA Serration Balloon CathEter

The objective of this registry is to collect observational data under local standard of care and evaluate safety and performance of the Serranator® in treatmen…

Peripheral Artery Disease (PAD)Dysfunctional AV FistulaDysfunctional AV Graft

Estimated

~$10 – $1,050

Cagent Vascular LLCNCT06687590

Phase 3

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the Incidence of Ischemia-Driven Major Amputation, Clinically Driven Target Lesion Revascularization, and Clinically Relevant Target Lesion Occlusion After Revascularization of Lesions Below the Knee in Patients With Symptomatic Rutherford 3-5 Peripheral Artery Disease

A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of i…

Peripheral Artery DiseaseCritical Limb Ischemia

Estimated

~$10 – $8,750

Mercator MedSystems, Inc.NCT04433572

Phase 2

Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease: The GPAD-3 Study

Peripheral artery disease (PAD) is a disease in which plaque builds up in the arteries that carry blood to the head, organs, and limbs. PAD usually occurs in t…

Peripheral Artery Disease (PAD)

Estimated

~$10 – $6,250

Emory UniversityNCT03304821